Barbara Kaproń

Development of the 1,2,4-triazole-based anticonvulsant drug candidates acting on the voltage-gated sodium channels. Insights from in-vivo, in-vitro, and in-silico studies

Barbara Kaproń, Jarogniew J. Łuszczki, Anita Płazińska et al. · European Journal of Pharmaceutical Sciences · 2018 · 73 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Search for factors affecting antibacterial activity and toxicity of 1,2,4-triazole-ciprofloxacin hybrids

Tomasz Plech, Barbara Kaproń, Agata Paneth et al. · European Journal of Medicinal Chemistry · 2015 · 68 citations · Full text

Medicine, Pharmacology, Toxicology +13

Studies on the anticonvulsant activity of 4-alkyl-1,2,4-triazole-3-thiones and their effect on GABAergic system

Tomasz Plech, Barbara Kaproń, Jarogniew J. Łuszczki et al. · European Journal of Medicinal Chemistry · 2014 · 63 citations · Full text

Medicine, Neuroscience, Pharmacology +12

1,2,4-Triazole-based anticonvulsant agents with additional ROS scavenging activity are effective in a model of pharmacoresistant epilepsy

Barbara Kaproń, Robert Czarnomysy, Mariusz Wysokiński et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2020 · 60 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Lichen-Derived Compounds and Extracts as Biologically Active Substances with Anticancer and Neuroprotective Properties

Elżbieta Studzińska-Sroka, Aleksandra Majchrzak‐Celińska, Przemysław Zalewski et al. · Pharmaceuticals · 2021 · 52 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17